Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter
(09 Feb 2026)

Back
Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales1041.26949.42 10
OPM %35.6630.75 -
PBDT402.27326.90 23
PBT381.95308.10 24
NP295.62229.88 29

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew